U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 201824
Company: MYLAN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CLOZAPINE CLOZAPINE 12.5MG TABLET, ORALLY DISINTEGRATING;ORAL None (Tentative Approval) None No No
CLOZAPINE CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No No
CLOZAPINE CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No No
CLOZAPINE CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No No
CLOZAPINE CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/15/2015 ORIG-2 Tentative Approval Not Applicable

Label is not available on this site.
09/15/2015 ORIG-1 Approval Not Applicable Letter (PDF)

Label is not available on this site.

 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/201824Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/26/2023 SUPPL-22 Labeling-Package Insert

Label is not available on this site.
11/10/2021 SUPPL-16 REMS - MODIFIED - D-N-A

Label is not available on this site.
07/29/2021 SUPPL-15 REMS - MODIFIED - D-N-A

Label is not available on this site.
02/18/2021 SUPPL-13 REMS - MODIFIED - D-N-A

Label is not available on this site.
07/26/2020 SUPPL-11 Labeling-Package Insert

Label is not available on this site.
01/16/2019 SUPPL-9 REMS - MODIFIED - D-N-A

Label is not available on this site.
11/17/2017 SUPPL-7 Labeling-Package Insert

Label is not available on this site.
01/22/2016 SUPPL-5 Labeling-Package Insert

Label is not available on this site.
01/22/2016 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

CLOZAPINE

TABLET, ORALLY DISINTEGRATING;ORAL; 25MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CLOZAPINE CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 090308 BARR LABS INC
CLOZAPINE CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 201824 MYLAN

TABLET, ORALLY DISINTEGRATING;ORAL; 100MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CLOZAPINE CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 090308 BARR LABS INC
CLOZAPINE CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 201824 MYLAN

TABLET, ORALLY DISINTEGRATING;ORAL; 150MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CLOZAPINE CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 201824 MYLAN
CLOZAPINE CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 203039 TEVA PHARMS USA

TABLET, ORALLY DISINTEGRATING;ORAL; 200MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CLOZAPINE CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 201824 MYLAN
CLOZAPINE CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 203039 TEVA PHARMS USA
Back to Top